High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients

被引:52
作者
Shafer, RW
Hertogs, K
Zolopa, AR
Warford, A
Bloor, S
Betts, BJ
Merigan, TC
Harrigan, R
Larder, BA
机构
[1] Stanford Univ, Med Ctr, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, AIDS Res Ctr, Stanford, CA 94305 USA
[3] Stanford Univ Hosp, Diagnost Virol Lab, Stanford, CA 94305 USA
[4] Stanford Univ Hosp, Dept Biostat, Stanford, CA 94305 USA
[5] VIRCO Belgium, Cent Virol Lab, Mechelen, Belgium
[6] VIRCO UK, Cambridge CB4 4GH, England
关键词
D O I
10.1128/JCM.39.4.1522-1529.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We assessed the reproducibility of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and protease sequencing using cryopreserved plasma aliquots obtained from 36 heavily treated HIV-1-infected individuals in two laboratories using: dideoxynucleotide sequencing. The rates of complete sequence concordance between the two laboratories were 99.1% for the protease sequence and 99.0% for the RT sequence. Approximately 90% of the discordances were partial, defined as one laboratory detecting a mixture and the second laboratory detecting only one of the mixture's components. Only 0.1% of the nucleotides were completely discordant between the two laboratories, and these were significantly more likely to occur in plasma samples with lower plasma HIV-I RNA levels, Nucleotide mixtures were detected at approximately 1% of the nucleotide positions, and in every case in which one laboratory detected a mixture, the second laboratory either detected the same mixture or detected one of the mixture's components. The high rate of concordance in detecting mixtures and the fact that most discordances between the two laboratories were partial suggest that most discordances were caused by variation in sampling of the HIV-1 quasispecies by PCR rather than by technical errors in the sequencing process itself.
引用
收藏
页码:1522 / 1529
页数:8
相关论文
共 29 条
  • [1] A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
    Baxter, JD
    Mayers, DL
    Wentworth, DN
    Neaton, JD
    Hoover, ML
    Winters, MA
    Mannheimer, SB
    Thompson, MA
    Abrams, DI
    Brizz, BJ
    Ioannidis, JPA
    Merigan, TC
    [J]. AIDS, 2000, 14 (09) : F83 - F93
  • [2] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
    Carpenter, CCJ
    Cooper, DA
    Fischl, MA
    Gatell, JM
    Gazzard, BG
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schechter, M
    Schooley, RT
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03): : 381 - 390
  • [3] D'Aquila RT, 2000, ANTIVIR THER, V5, P71
  • [4] DeGruttola V, 2000, ANTIVIR THER, V5, P41
  • [5] Demeter LM, 1998, J VIROL METHODS, V75, P93, DOI 10.1016/S0166-0934(98)00100-1
  • [6] Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001
  • [7] Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial
    Durant, J
    Clevenbergh, P
    Halfon, P
    Delgiudice, P
    Porsin, S
    Simonet, P
    Montagne, N
    Boucher, CAB
    Schapiro, JM
    Dellamonica, P
    [J]. LANCET, 1999, 353 (9171) : 2195 - 2199
  • [8] Felsenstein J., 1993, PHYLIP PHYLOGENY INF
  • [9] Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples
    Günthard, HF
    Wong, JK
    Ignacio, CC
    Havlir, DV
    Richman, DD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (10) : 869 - 876
  • [10] HAMMOND J, 1998, HUMAN RETROVIRUSES A